Osnat Naftali

Osnat Naftali is a professional with extensive experience in business development and investment consulting. Currently serving as a Business Development Manager at Beilinson Innovation since July 2022, Osnat also holds the position of Investment Consultant and Office Manager at Oak Capital since April 2019. Previous roles include Research Associate at KadimaStem from December 2015 to March 2018, focusing on cell therapy for diabetes, and at Tel Aviv University from December 2014 to December 2015, studying metastasis progression. Osnat Naftali earned an MBA in Healthcare Innovation from Reichman University in 2021 and holds a Master's Degree in Cell/Cellular and Molecular Biology and a Bachelor's Degree in Biotechnology, both from Tel Aviv University.